5 years ago

Closed Loop Medicine Secures €275K for COVID-19 and Hypertension Monitoring

  • Closed Loop Medicine (CLM), a UK-based therapeutics and healthtech startup, has secured a €275K COVID-19 Innovate UK Continuity Funding award to support its ongoing clinical research program

  • The funding will allow CLM to continue its clinical studies, which were placed on hold due to the COVID-19 pandemic

  • The study, which is being run in partnership with the William Harvey Clinical Research Centre (WHCRC), Queen Mary University of London, will test ways of adding carefully tuned medication to patients with high blood pressure, even during lockdown or restricted movement

  • The goal is to improve blood pressure control and save lives through fewer heart attacks and strokes.

      • ProblemHealthtech

      "Making it possible to monitor blood pressure and COVID-19 symptoms through a personalized digital app for patients in their homes, allowing for better treatment and preventing heart attacks and strokes."

      Solution

      "Closed Loop Medicine has developed a precision drug and digital therapy package for patients with high blood pressure, and is now expanding this package to allow patients to track COVID-19 symptoms remotely, with the goal of improving blood pressure control and saving thousands of lives."

      Covered on